Page last updated: 2024-08-24

2-methoxyestradiol and Neurofibromatosis 1

2-methoxyestradiol has been researched along with Neurofibromatosis 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barald, KF; Cevallos, S; Dohle, W; Ferrer-Torres, D; Hsia, T; Jewett, DM; Leese, MP; Messick, RJ; Potter, BV; Roth, TM; Shen, YC; Upadhyayula, R	1

Other Studies

1 other study(ies) available for 2-methoxyestradiol and Neurofibromatosis 1

Article	Year
Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol. British journal of cancer, 2015, Oct-20, Volume: 113, Issue:8 Topics: 2-Methoxyestradiol; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cytoskeleton; Estradiol; Estrogens; Humans; Neurofibroma, Plexiform; Neurofibromatosis 1; Neurofibromin 1; Phosphatidylinositol 3-Kinases; Progesterone; Signal Transduction; Small Molecule Libraries; TOR Serine-Threonine Kinases	2015

Article

Year

Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.

British journal of cancer, 2015, Oct-20, Volume: 113, Issue:8

Topics: 2-Methoxyestradiol; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cytoskeleton; Estradiol; Estrogens; Humans; Neurofibroma, Plexiform; Neurofibromatosis 1; Neurofibromin 1; Phosphatidylinositol 3-Kinases; Progesterone; Signal Transduction; Small Molecule Libraries; TOR Serine-Threonine Kinases

2015